Clinical Trials in Salt Lake City

Showing 11041-11060 of 16,694 trials

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

NCT02537574

This study will evaluate the safety, effectiveness and tolerance of low doses of oral naltrexone along with buprenorphine to treat opioid use disorder prior to the first injection of VIVITROL.

Opioid Use Disorder

Alkermes, Inc.380 participantsStarted Aug 2015

Oceanside, California, United States • Orange, California, United States • Lauderhill, Florida, United States +17 more locations

TERMINATEDPhase 2< 1 mile

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

NCT00927784

Left ventricular assist devices (LVADs) are one treatment option for people with congestive heart failure. This study will evaluate the safety of injecting mesenchymal precursor cells (MPCs) into the heart during LVAD implantation surgery and examine if injecting MPCs into the heart is effective at improving heart function.

Heart Failure

Icahn School of Medicine at Mount Sinai10 participantsStarted Aug 2009

San Diego, California, United States • Washington D.C., District of Columbia, United States • Oak Lawn, Illinois, United States +14 more locations

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Find Trials by Condition in Salt Lake City

Driveline Silicone Skin Interface Registry

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

Inflammation and the Host Response to Injury (Trauma)

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE)

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Dating Matters: Strategies to Promote Healthy Teen Relationships